FEATURES OF THE DEBUT OF ACUTE MYOCARDITIS IN PATIENTS AFTER COVID-19 INFECTION

Authors:

Abstract:

The purpose of the study was to perform a comparative assessment and analysis of the relationship between parameters of immune status and the structural and functional state of the heart in patients with acute myocarditis who had or did not have a history of COVID-19 infection. According to the results of the study, patients with acute myocarditis and a history of COVID-19 infection were characterized by a larger volume of inflammatory and fibrotic damage to the myocardium and more pronounced violations of the contractility of the left ventricle compared to patients who did not have a history of coronavirus infection. In addition, patients with myocarditis and previous coronavirus infection were characterized by a more pronounced activation of immunopathological reactions, which was accompanied by a higher level of C-reactive protein, pro-inflammatory interleukin-6, ferritin and troponin I as a marker of cardiomyocyte damage. The use of factor analysis made it possible to establish the limit values of instrumental and laboratory indicators associated with the presence of widespread inflammatory/fibrotic lesions of the left ventricle in patients with acute myocarditis and history of COVID-19: the values of left ventricle longitudinal, global systolic strain of the ≤9.0 % and the left ventricle end-diastolic volume index ≥95 ml/m2, as well as the content of tumor necrosis factor-α ≥7.5 pg/mL and C-reactive protein ≥12.0 mcg/ml in blood serum.

Keywords:

acute myocarditis coronavirus infection immunopathological reactions left ventricle global systolic strain inflammatory and fibrotic changes in the heart

References:

1. Kovalenko VM, Lutay MI, Sirenko YuM, Sychov OS, redaktory. Sertsevo-sudynni zakhvoryuvannya: klasyfikatsiya, standarty diahnostyky ta likuvannya. Kyiv: MORION. 2020; 239 s. [in Ukrainian]
2. Kovalenko VM, Nesukay OH, Chernyuk SV, Kozlyuk AS, Kyrychenko RM. Diahnostyka ta likuvannya miokardytu. Rekomendatsiyi Vseukrayinskoyi asotsiatsiyi kardiolohiv Ukrayiny. Ukrayinskyy kardiolohichnyy zhurnal. 2021; 32(3):67–88.doi:10.31928/1608-635X-2021.3.6788 [in Ukrainian]
3. Arnold JR, McCann GP. Cardiovascular Magnetic Resonance: Applications and Practical Considerations for the General Cardiologist. Heart. 2020; 106(3):174–181. doi: 10.1136/heartjnl-2019-314856.
4. Azevedo RB, Botelho BG, de Hollanda JVG, Ferreira LVL, Junqueira de Andrade LZ, Oei SSML et al. “Covid-19 and the cardiovascular system: a comprehensive review,” J Hum Hypertens. 2020; 35(1):4–11. doi: 10.1038/s41371-020-0387-4.
5. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB et al. Current state of knowledge on aetiology, diagnosis, management and therapy of myocarditis: a position statement of the ESC Working group on myocardial and pericardial diseases. Eur Heart J. 2013; 34(33): 2636–48. doi: 10.1093/eurheartj/eht210.
6. Chaulin AM. The Metabolic Pathway of Cardiac Troponins Release: Mechanisms and Diagnostic Role. Cardiol Res. 2022; 13(4):190-205. doi: 10.14740/cr1351. Epub 2022 Aug 15. PMID: 36128422; PMCID: PMC9451590
7. González-Ruiz FJ, Lazcano-Díaz EA, Vásquez-Ortiz ZY, Bernal-Ceballos F. Comprehensive Left Ventricular Mechanics Analysis by Speckle Tracking Echocardiography in COVID-19. World Journal of Cardiovascular Diseases. 2021; 11:113–125. doi: 10.4236/wjcd.2021.112013.
8. Goody P, Zimmer S, Zimmer A, Kreuz J, Becher M, Isaak A et al. 3D-speckle-tracking echocardiography correlates with CMR diagnosis of acute myocarditis. Int J Cardiol Heart Vasc. 2021; 17:549–563. doi: 10.22541/au.161359840.05297135/v1.
9. Kaushal K, Kaur H, Sarma P, Bhattacharyya A, Sharma DJ, Prajapat M et al. Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis. J Crit Care. 2022; 67:172–181. doi:10.1016/j.jcrc.2021.09.023.
10. Kostakou PM, Kostopoulos VS, Tryfou ES, Giannaris VD, Rodis IE, Olympios CD et al. Subclinical left ventricular dysfunction and correlation with regional strain analysis in myocarditis with normal ejection fraction. A new diagnostic criterion. Int J Cardiol. 2018; 259:116–121. doi: 10.1016/j.ijcard.2018.01.058.
11. Lang R, Badano LP, Mor-Avi V, Afilalo J, Armstron A, Ernande L et al. Recommendations for cardiac chamber quantification in adults: an update from the American Society of echocardiography and European Asssociation of cardiovascular imaging. J. Am. Soc. Echocardiogr. 2015; 28(1):1–38. doi: 10.1016/j.echo.2014.10.003.
12. Liu T, Zhang J, Yang Y, Ma H, Li Z, Cheng J et al. X. The potential role of IL-6 in monitoring severe case of coronavirus disease. EMBO Mol Med. 2020; 12(7): e12421. doi: 10.15252/emmm.202012421. Epub 2020 Jun 5. PMID: 32428990 PMCID: PMC7280589
13. Para O, Caruso L, Pestelli G, Tangianu F, Carrara D, Maddaluni L et al. Ferritin as prognostic marker in COVID-19: the FerVid study. Postgrad Med. 2022; 134(1):58–63. doi: 10.1080/00325481.2021.1990091. Epub 2021 Oct 17. PMID: 34613875; PMCID: PMC8544665.
14. Tschöpe C, Ammirati E, Bozkurt B, Caforio AL, Cooper LT, Felix SB, Hare JM et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021; 18(3):169–193. doi: 10.1038/s41569-020-00435-x.
15. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 2020; 17(5):259–260. doi: 10.1038/s41569-020-0360-5.

Publication:

«World of Medicine and Biology» Vol. 19 No. 84 (2023) , с. 87-92
УДК 616.127-002-073

DOI:

https://doi.org/10.26724/2079-8334-2023-2-84-87-92